The CDMO industry is undergoing a fundamental transformation, driven by the growing complexity of new drug modalities ...

Key Takeaways. Draft guidance targets reduction/elimination of nonhuman primate testing for monoclonal antibodies, signaling higher regulatory receptivity to alternative nonclinic ...

Pharmaceutical importers benefit directly because IEEPA-derived tariffs on finished drugs and ingredients are refund-eligible ...

Drug shortages are rising. Learn what's breaking the pharmaceutical supply chain, and what industry leaders are doing to fix ...

Ranjit Deshmukh, Principal, BiologixCMC, discusses how contract manufacturers can optimize their processes and plan for the ...

Asahi Kasei acquires Aicuris, adding three antiviral assets targeting immunocompromised patients, with combined revenue ...

Legacy packaging paradigms impede sustainability gains; early lifecycle management decisions, even for secondary components ...

CS Analytical, discusses how sustainability in pharmaceutical packaging can be improved. Advertisement. Latest Updated ...

European Frontrunners Columnist, Cheryl Barton, focuses on European biotechs leveraging AI, multi-omics, and cell therapies to address the root causes of cardiovascular disease, driving a market ...

Full FDA approval covers proteinuria reduction in FSGS without nephrotic syndrome, a defined clinical subset differentiated ...

In this clip from episode 1 of Manufacturing Intelligence, Richard Jaenisch of Open Biopharma discusses uses of AI for ...

FDA–EU GMP mutual recognition enables FDA reliance on EU inspections, particularly supporting surveillance oversight for Novo ...